Kenya receives Sh400 million for syringe manufacturing

Most low and middle-income countries have been depending on supply of syringes from India and China, before the global pandemic which increased demand. [iStockphoto]

Kenya’s leading medical supply manufacturer has received funds to manufacture syringes, amid looming shortfalls besides efforts to ramp up fight against the Covid-19 pandemic Revital Healthcare (EPZ) Ltd has received $4 million (Sh400 million) from Bill & Melinda Gates Foundation to expand production of auto-disable syringes from about 72 million to 265 million annually, towards the end of 2022.

Bill & Melinda Gates Foundation estimates that the supply will cover more than half of the routine immunization needs in Africa.